Today, Paxman publishes the company’s annual report for 2022.

The annual report in Swedish and a condensed English version is available on Paxman’s website. A printed copy of the annual report can be ordered by emailing the company’s CFO Emelie Gustafsson, emelie.gustafsson@paxman.se.

Use the links below for quick access to the annual report.

Swedish version: https://bit.ly/paxar22se
Condensed English version: https://bit.ly/paxar22en

The annual report was created in collaboration with Paxman’s IR communication partner Honeybadger, https://www.honeybadger.se

Contacts

Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 4,400 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.

Attachments

PAXMAN AR 2022 ENG

© Modular Finance, source Nordic Press Releases